These results suggest that the CFG could be used on its own to treat ovarian cancer patients In addition, the microarray result and our preliminary experiments, indicated that CFG regulates ovarian cancer cell proliferation and migration via the AKT/GSK3β signaling pathway, which suggests that the CFG may target a molecular component of this pathway. The gene discussed is AKT1; the disease is ovarian carcinoma.